These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 8663147

  • 21. Myocardial infarction and the balance between fibrin deposition and removal.
    Nesheim M.
    Ital Heart J; 2001 Sep; 2(9):641-5. PubMed ID: 11666089
    [Abstract] [Full Text] [Related]

  • 22. Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans.
    Mao SS, Cooper CM, Wood T, Shafer JA, Gardell SJ.
    J Biol Chem; 1999 Dec 03; 274(49):35046-52. PubMed ID: 10574983
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Activation of protein C and thrombin activable fibrinolysis inhibitor on cultured human endothelial cells.
    Wu C, Kim PY, Swystun LL, Liaw PC, Weitz JI.
    J Thromb Haemost; 2016 Feb 03; 14(2):366-74. PubMed ID: 26663133
    [Abstract] [Full Text] [Related]

  • 31. Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis.
    Mosnier LO, Bouma BN.
    Arterioscler Thromb Vasc Biol; 2006 Nov 03; 26(11):2445-53. PubMed ID: 16960106
    [Abstract] [Full Text] [Related]

  • 32. Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis.
    Miljić P, Heylen E, Willemse J, Djordjević V, Radojković D, Colović M, Elezović I, Hendriks D.
    Srp Arh Celok Lek; 2010 Jan 03; 138 Suppl 1():74-8. PubMed ID: 20229688
    [Abstract] [Full Text] [Related]

  • 33. Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway.
    Colucci M, Incampo F, Cannavò A, Menegatti M, Siboni SM, Zaccaria F, Semeraro N, Peyvandi F.
    J Thromb Haemost; 2016 Aug 03; 14(8):1603-14. PubMed ID: 27094709
    [Abstract] [Full Text] [Related]

  • 34. Total thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and pro-TAFI in patients with haemophilia A.
    Antovic J, Schulman S, Eelde A, Blombäck M.
    Haemophilia; 2001 Nov 03; 7(6):557-60. PubMed ID: 11851753
    [Abstract] [Full Text] [Related]

  • 35. Amino acid residues in the P6-P'3 region of thrombin-activable fibrinolysis inhibitor (TAFI) do not determine the thrombomodulin dependence of TAFI activation.
    Schneider M, Nagashima M, Knappe S, Zhao L, Morser J, Nesheim M.
    J Biol Chem; 2002 Mar 22; 277(12):9944-51. PubMed ID: 11786552
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation.
    Wang W, Nagashima M, Schneider M, Morser J, Nesheim M.
    J Biol Chem; 2000 Jul 28; 275(30):22942-7. PubMed ID: 10801821
    [Abstract] [Full Text] [Related]

  • 38. Thrombin-activatable fibrinolysis inhibitor.
    Marx PF.
    Curr Med Chem; 2004 Sep 28; 11(17):2335-48. PubMed ID: 15379716
    [Abstract] [Full Text] [Related]

  • 39. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma.
    Broze GJ, Higuchi DA.
    Blood; 1996 Nov 15; 88(10):3815-23. PubMed ID: 8916945
    [Abstract] [Full Text] [Related]

  • 40. Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.
    Schneider M, Boffa M, Stewart R, Rahman M, Koschinsky M, Nesheim M.
    J Biol Chem; 2002 Jan 11; 277(2):1021-30. PubMed ID: 11684677
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.